240 related articles for article (PubMed ID: 25449596)
1. Polyoxometalates--potent and selective ecto-nucleotidase inhibitors.
Lee SY; Fiene A; Li W; Hanck T; Brylev KA; Fedorov VE; Lecka J; Haider A; Pietzsch HJ; Zimmermann H; Sévigny J; Kortz U; Stephan H; Müller CE
Biochem Pharmacol; 2015 Jan; 93(2):171-81. PubMed ID: 25449596
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.
al-Rashida M; Iqbal J
Med Res Rev; 2014 Jul; 34(4):703-43. PubMed ID: 24115166
[TBL] [Abstract][Full Text] [Related]
3. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases.
Lévesque SA; Lavoie EG; Lecka J; Bigonnesse F; Sévigny J
Br J Pharmacol; 2007 Sep; 152(1):141-50. PubMed ID: 17603550
[TBL] [Abstract][Full Text] [Related]
4. Ecto-nucleotidase inhibitors: recent developments in drug discovery.
Baqi Y
Mini Rev Med Chem; 2015; 15(1):21-33. PubMed ID: 25694081
[TBL] [Abstract][Full Text] [Related]
5. Extracellular ATP Selectively Upregulates Ecto-Nucleoside Triphosphate Diphosphohydrolase 2 and Ecto-5'-Nucleotidase by Rat Cortical Astrocytes In Vitro.
Brisevac D; Adzic M; Laketa D; Parabucki A; Milosevic M; Lavrnja I; Bjelobaba I; Sévigny J; Kipp M; Nedeljkovic N
J Mol Neurosci; 2015 Nov; 57(3):452-62. PubMed ID: 26080748
[TBL] [Abstract][Full Text] [Related]
6. Thiazolo[3,2-a]benzimidazol-3(2H)-one derivatives: Structure-activity relationships of selective nucleotide pyrophosphatase/phosphodiesterase1 (NPP1) inhibitors.
Lee SY; Perotti A; De Jonghe S; Herdewijn P; Hanck T; Müller CE
Bioorg Med Chem; 2016 Jul; 24(14):3157-65. PubMed ID: 27265686
[TBL] [Abstract][Full Text] [Related]
7. Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.
Baqi Y; Lee SY; Iqbal J; Ripphausen P; Lehr A; Scheiff AB; Zimmermann H; Bajorath J; Müller CE
J Med Chem; 2010 Mar; 53(5):2076-86. PubMed ID: 20146483
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors.
Lee SY; Müller CE
Medchemcomm; 2017 May; 8(5):823-840. PubMed ID: 30108800
[TBL] [Abstract][Full Text] [Related]
10. Imidazopyridine- and purine-thioacetamide derivatives: potent inhibitors of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1).
Chang L; Lee SY; Leonczak P; Rozenski J; De Jonghe S; Hanck T; Müller CE; Herdewijn P
J Med Chem; 2014 Dec; 57(23):10080-100. PubMed ID: 25372276
[TBL] [Abstract][Full Text] [Related]
11. Polyoxometalates--a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors.
Müller CE; Iqbal J; Baqi Y; Zimmermann H; Röllich A; Stephan H
Bioorg Med Chem Lett; 2006 Dec; 16(23):5943-7. PubMed ID: 16997558
[TBL] [Abstract][Full Text] [Related]
12. Acidosis is a key regulator of osteoblast ecto-nucleotidase pyrophosphatase/phosphodiesterase 1 (NPP1) expression and activity.
Orriss IR; Key ML; Hajjawi MO; Millán JL; Arnett TR
J Cell Physiol; 2015 Dec; 230(12):3049-56. PubMed ID: 26033523
[TBL] [Abstract][Full Text] [Related]
13. Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors.
Eliahu S; Lecka J; Reiser G; Haas M; Bigonnesse F; Lévesque SA; Pelletier J; Sévigny J; Fischer B
J Med Chem; 2010 Dec; 53(24):8485-97. PubMed ID: 21090681
[TBL] [Abstract][Full Text] [Related]
14. Ectonucleotidases and nucleotide/nucleoside transporters as pharmacological targets for neurological disorders.
Bonan CD
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):739-50. PubMed ID: 22963442
[TBL] [Abstract][Full Text] [Related]
15. Highly Potent and Selective Ectonucleoside Triphosphate Diphosphohydrolase (ENTPDase1, 2, 3 and 8) Inhibitors Having 2-substituted-7- trifluoromethyl-thiadiazolopyrimidones Scaffold.
Afzal S; Zaib S; Jafari B; Langer P; Lecka J; Sévigny J; Iqbal J
Med Chem; 2020; 16(5):689-702. PubMed ID: 31203806
[TBL] [Abstract][Full Text] [Related]
16. Cellular function and molecular structure of ecto-nucleotidases.
Zimmermann H; Zebisch M; Sträter N
Purinergic Signal; 2012 Sep; 8(3):437-502. PubMed ID: 22555564
[TBL] [Abstract][Full Text] [Related]
17. Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study.
Lecka J; Ben-David G; Simhaev L; Eliahu S; Oscar J; Luyindula P; Pelletier J; Fischer B; Senderowitz H; Sévigny J
J Med Chem; 2013 Nov; 56(21):8308-20. PubMed ID: 24083941
[TBL] [Abstract][Full Text] [Related]
18. The effects of angiotensin II and genetic hypertension upon extracellular nucleotide hydrolysis by rat platelet ectoenzymes.
Fürstenau CR; Trentin DS; Barreto-Chaves ML; Sarkis JJ
Thromb Res; 2007; 120(6):877-84. PubMed ID: 17343900
[TBL] [Abstract][Full Text] [Related]
19. Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities.
Yegutkin GG
Crit Rev Biochem Mol Biol; 2014; 49(6):473-97. PubMed ID: 25418535
[TBL] [Abstract][Full Text] [Related]
20. Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor.
Mahmut A; Boulanger MC; Bouchareb R; Hadji F; Mathieu P
Cardiovasc Res; 2015 Apr; 106(1):109-20. PubMed ID: 25644539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
